960151-86-4

Basic information

• Product Name: ethyl 4-hydroxy-4-(2-(4-tolylsulfanyl)phenyl)piperidin-1-carboxylate
• Synonyms: ethyl 4-hydroxy-4-(2-(4-tolylsulfanyl)phenyl)piperidin-1-carboxylate
• CAS NO: 960151-86-4
• Molecular Weight: 371.5
• Mol File: 960151-86-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: ethyl 4-hydroxy-4-(2-(4-tolylsulfanyl)phenyl)piperidin-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-hydroxy-4-(2-(4-tolylsulfanyl)phenyl)piperidin-1-carboxylate(960151-86-4)
• EPA Substance Registry System: ethyl 4-hydroxy-4-(2-(4-tolylsulfanyl)phenyl)piperidin-1-carboxylate(960151-86-4)

Safety Data

• Hazardous Substances Data: 960151-86-4(Hazardous Substances Data)

Upstream product

• 583-53-9 2,3-dibromobenzene 
• 106-45-6 para-thiocresol 
• 15861-49-1 1-bromo-2-(4-methylphenylsulfanyl)benzene 
• 29976-53-2 N-ethoxycarbonyl-4-piperidone 

Downstream Products

• 960151-84-2 Tedatioxetine phosphate 
• 960151-65-9 Tedatioxetine hydrobromide 
• 508233-95-2 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine 
• 960151-74-0 4-(2-(4-tolylsulfanyl)phenyl)piperidin palmitate 
• 960151-77-3 Tedatioxetine fumarate 
• 960151-81-9 4-(2-(4-tolylsulfanyl)phenyl)piperidin monomalate 
• 1058738-31-0 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine hydrochloride 
• 960151-75-1 4-(2-(4-tolylsulfanyl)phenyl)piperidin monoadipate 
• 960151-69-3 4-(2-(4-tolylsulfanyl)phenyl)piperidin mono-L-aspartate 
• 960151-67-1 4-(2-(4-tolylsulfanyl)phenyl)piperidin monoglutarate 
• 960151-68-2 Tedatioxetine malonate 
• 960151-78-4 Tedatioxetine oxalate 
• 960151-66-0 Tedatioxetine lactate 

Relevant articles and documents

Therapeutic Uses Of Compounds Having Affinity To The Serotonin Transporter, Serotonin Receptors And Noradrenalin Transporter

Therapeutic uses of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine and therapeutically acceptable salts thereof are provide.

PROCESS FOR THE MANUFACTURE OF [PHENYLSULFANYLPHENYL]PIPERIDINES

A process for the manufacture of (un)substituted phenylsulfanylphenyl-piperidines comprising the use of benzyl as N-piperidine protecting group is disclosed.

CRYSTALLINE FORMS OF 4- [2- (4-METHYLPHENYLSULFANYL) -PHENYL] PIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN

Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine and salts thereof are provided e.g. for the treatment of neuropathic pain.